Profile | GDS5420 / 206916_x_at |
Title | Psoriasis response to brodalumab: dose response and time course |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM1296094 | A_lesional_pre-dose | 805.89 | 75 |
GSM1296119 | B_lesional_pre-dose | 739.02 | 74 |
GSM1296076 | C_lesional_pre-dose | 765.64 | 75 |
GSM1296092 | D_lesional_pre-dose | 498.3 | 68 |
GSM1296103 | E_lesional_pre-dose | 627.84 | 71 |
GSM1296078 | F_lesional_pre-dose | 690.58 | 74 |
GSM1296107 | G_lesional_pre-dose | 856.66 | 77 |
GSM1296109 | H_lesional_pre-dose | 922.24 | 78 |
GSM1296080 | I_lesional_pre-dose | 856.21 | 76 |
GSM1296090 | J_lesional_pre-dose | 581.52 | 71 |
GSM1296074 | K_lesional_pre-dose | 599.12 | 71 |
GSM1296111 | L_lesional_pre-dose | 687.61 | 73 |
GSM1296099 | M_lesional_pre-dose | 600 | 70 |
GSM1296086 | O_lesional_pre-dose | 582.39 | 71 |
GSM1296117 | P_lesional_pre-dose | 745.5 | 75 |
GSM1296113 | Q_lesional_pre-dose | 846.63 | 77 |
GSM1296096 | R_lesional_pre-dose | 633.46 | 71 |
GSM1296105 | S_lesional_pre-dose | 629.65 | 71 |
GSM1296098 | T_lesional_pre-dose | 1215.22 | 82 |
GSM1296101 | U_lesional_pre-dose | 784.37 | 75 |
GSM1296121 | V_lesional_pre-dose | 776.97 | 75 |
GSM1296088 | W_lesional_pre-dose | 735.51 | 74 |
GSM1296082 | X_lesional_pre-dose | 641.24 | 72 |
GSM1296115 | Y_lesional_pre-dose | 654.79 | 72 |
GSM1296084 | Z_lesional_pre-dose | 789.59 | 75 |
GSM1296072 | B_lesional_day8 | 783.76 | 75 |
GSM1296069 | L_lesional_day8 | 743.02 | 74 |
GSM1296071 | P_lesional_day8 | 712.36 | 74 |
GSM1296070 | Y_lesional_day8 | 615.08 | 71 |
GSM1296073 | V_lesional_day8 | 794.77 | 76 |
GSM1296034 | A_lesional_day15 | 1015.91 | 79 |
GSM1296041 | G_lesional_day15 | 727.83 | 74 |
GSM1296035 | R_lesional_day15 | 574.53 | 70 |
GSM1296038 | U_lesional_day15 | 587.87 | 70 |
GSM1296047 | B_lesional_day15 | 818.84 | 76 |
GSM1296039 | E_lesional_day15 | 595.41 | 71 |
GSM1296042 | H_lesional_day15 | 767.35 | 75 |
GSM1296043 | L_lesional_day15 | 803.36 | 76 |
GSM1296037 | M_lesional_day15 | 938.31 | 78 |
GSM1296046 | P_lesional_day15 | 674.53 | 73 |
GSM1296044 | Q_lesional_day15 | 835.25 | 76 |
GSM1296045 | Y_lesional_day15 | 719.55 | 74 |
GSM1296025 | C_lesional_day15 | 673.14 | 73 |
GSM1296033 | D_lesional_day15 | 635.44 | 71 |
GSM1296027 | I_lesional_day15 | 746.78 | 74 |
GSM1296032 | J_lesional_day15 | 675.7 | 72 |
GSM1296024 | K_lesional_day15 | 716.2 | 74 |
GSM1296031 | W_lesional_day15 | 764.43 | 74 |
GSM1296028 | X_lesional_day15 | 711.13 | 73 |
GSM1296029 | Z_lesional_day15 | 687.32 | 73 |
GSM1296026 | F_lesional_day15 | 671.86 | 73 |
GSM1296030 | O_lesional_day15 | 594.36 | 71 |
GSM1296040 | S_lesional_day15 | 690.64 | 73 |
GSM1296036 | T_lesional_day15 | 823.58 | 76 |
GSM1296048 | V_lesional_day15 | 717.73 | 74 |
GSM1296059 | A_lesional_day43 | 693.9 | 73 |
GSM1296066 | G_lesional_day43 | 764.96 | 75 |
GSM1296060 | R_lesional_day43 | 544.07 | 69 |
GSM1296063 | U_lesional_day43 | 530.46 | 69 |
GSM1296064 | E_lesional_day43 | 502.58 | 68 |
GSM1296067 | H_lesional_day43 | 757.34 | 74 |
GSM1296062 | M_lesional_day43 | 731.45 | 74 |
GSM1296068 | Q_lesional_day43 | 723.66 | 74 |
GSM1296050 | C_lesional_day43 | 768.51 | 75 |
GSM1296057 | D_lesional_day43 | 645.72 | 72 |
GSM1296052 | I_lesional_day43 | 663.57 | 72 |
GSM1296054 | J_lesional_day43 | 787.84 | 75 |
GSM1296049 | K_lesional_day43 | 953.87 | 78 |
GSM1296055 | W_lesional_day43 | 772.47 | 75 |
GSM1296053 | X_lesional_day43 | 917.5 | 78 |
GSM1296058 | Z_lesional_day43 | 701.01 | 73 |
GSM1296051 | F_lesional_day43 | 672.7 | 73 |
GSM1296056 | O_lesional_day43 | 717.35 | 74 |
GSM1296065 | S_lesional_day43 | 537.43 | 69 |
GSM1296061 | T_lesional_day43 | 1020.12 | 79 |
GSM1296095 | A_non-lesional_pre-dose | 629.66 | 72 |
GSM1296120 | B_non-lesional_pre-dose | 860.67 | 77 |
GSM1296077 | C_non-lesional_pre-dose | 767.33 | 75 |
GSM1296093 | D_non-lesional_pre-dose | 935.85 | 78 |
GSM1296104 | E_non-lesional_pre-dose | 692.05 | 73 |
GSM1296079 | F_non-lesional_pre-dose | 635.47 | 72 |
GSM1296108 | G_non-lesional_pre-dose | 892.21 | 77 |
GSM1296110 | H_non-lesional_pre-dose | 887.23 | 77 |
GSM1296081 | I_non-lesional_pre-dose | 1199.95 | 82 |
GSM1296091 | J_non-lesional_pre-dose | 535.74 | 69 |
GSM1296075 | K_non-lesional_pre-dose | 628.1 | 72 |
GSM1296112 | L_non-lesional_pre-dose | 875.3 | 77 |
GSM1296100 | M_non-lesional_pre-dose | 860.63 | 77 |
GSM1296087 | O_non-lesional_pre-dose | 691.01 | 73 |
GSM1296118 | P_non-lesional_pre-dose | 831.8 | 76 |
GSM1296114 | Q_non-lesional_pre-dose | 945.5 | 79 |
GSM1296097 | R_non-lesional_pre-dose | 595.7 | 71 |
GSM1296106 | S_non-lesional_pre-dose | 704.02 | 73 |
GSM1296102 | U_non-lesional_pre-dose | 822.02 | 76 |
GSM1296122 | V_non-lesional_pre-dose | 844.74 | 77 |
GSM1296089 | W_non-lesional_pre-dose | 813.89 | 76 |
GSM1296083 | X_non-lesional_pre-dose | 1081.35 | 80 |
GSM1296116 | Y_non-lesional_pre-dose | 758.99 | 75 |
GSM1296085 | Z_non-lesional_pre-dose | 781.27 | 75 |